Probe substrates assay estimates the effect of polyphyllin H on the activity of cytochrome P450 enzymes in human liver microsomes

被引:0
作者
Wang, Erhao [1 ]
Wang, Mengxi [2 ]
Gao, Ming [3 ]
机构
[1] Hainan Women & Childrens Med Ctr, Pharm Dept, Haikou, Hainan, Peoples R China
[2] Seafarers Gen Hosp Heilongjiang Prov, Heilongjiang Hosp 6, Pharm Dept, Harbin, Heilongjiang, Peoples R China
[3] Chengdu Univ Chinese Med, Affiliated Hosp, Pharm Dept, 39 Shierqiao Rd, Chengdu 610072, Sichuan, Peoples R China
来源
PHARMACOLOGY RESEARCH & PERSPECTIVES | 2024年 / 12卷 / 05期
关键词
CYP450; drug-drug interaction; IC50; Rhizoma paridis (Liliaceae); time-dependent inhibition; IN-VITRO; INHIBITION; METABOLISM; PREDICTION; 3A4;
D O I
10.1002/prp2.70002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 enzymes (CYPs) play a crucial role in phase I metabolic reactions. The activity of CYPs would affect therapeutic efficacy and may even induce toxicity. Given the complex components of traditional Chinese medicine, it is important to understand the effect of active ingredients on CYPs activity to guide their prescription. This study aimed to evaluate the effect of polyphyllin H on the activity of CYPs major isoforms providing a reference for the clinical prescription of polyphyllin H and its source herbs. The effects of polyphyllin H were evaluated in pooled human liver microsomes using probe substrates of CYP1A2, 2A6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4 to determine their activities. The Lineweaver-Burk was used to model the inhibition, and a time-dependent inhibition experiment was performed to understand the characteristics of the inhibition. Polyphyllin H significantly suppressed the activity of CYP1A2, 2D6, and 3A4 with IC50 values of 6.44, 13.88, and 4.52 mu M, respectively. The inhibition of CYP1A2 and 2D6 was best fitted with a competitive model, yielding the inhibition constant (K-i) values of 3.18 and 6.77 mu M, respectively. The inhibition of CYP3A4 was fitted with the non-competitive model with the K-i value of 2.38 mu M. Moreover, the inhibition of CYP3A4 was revealed to be time-dependent with the inhibition parameters inhibition constant (KI) and inactivation rate constant (K-inact) values of 2.26 mu M-1 and 0.045 min(-1). Polyphyllin H acted as a competitive inhibitor of CYP1A2 and 2D6 and a non-competitive and time-dependent inhibitor of CYP3A4.
引用
收藏
页数:10
相关论文
共 49 条
  • [1] Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS297, DOI [10.1111/bph.14752, 10.1111/bph.14749]
  • [2] A preparative small- molecule mimic of liver CYP450 enzymes in the aliphatic C-H oxidation of carbocyclic N-heterocycles
    Chambers, Rachel K.
    Weaver, Jacob D.
    Kim, Jinho
    Hoar, Jason L.
    Krska, Shane W.
    White, M. Christina
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (29)
  • [3] Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles
    Chamboko, Chiratidzo R.
    Veldman, Wayde
    Tata, Rolland Bantar
    Schoeberl, Birgit
    Bishop, Ozlem Tastan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [4] Competitive, reversible, physiological? Inhibition of mitochondrial cytochrome oxidase by nitric oxide
    Cooper, CE
    [J]. IUBMB LIFE, 2003, 55 (10-11) : 591 - 597
  • [5] Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity
    Franca Quintanilha, Julia Coelho
    de Sousa, Vanessa Marcilio
    Visacri, Marilia Berlofa
    Amaral, Lais Sampaio
    Maia Santos, Roseane Maria
    Zambrano, Tomas
    Salazar, Luis Antonio
    Moriel, Patricia
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (02) : 223 - 233
  • [6] CYP1A2 genotype and acute ergogenic effects of caffeine intake on exercise performance: a systematic review
    Grgic, Jozo
    Pickering, Craig
    Del Coso, Juan
    Schoenfeld, Brad J.
    Mikulic, Pavle
    [J]. EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (03) : 1181 - 1195
  • [7] Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2
    Guo, Jingchao
    Zhu, Xiaohui
    Badawy, Sara
    Ihsan, Awais
    Liu, Zhenli
    Xie, Changqing
    Wang, Xu
    [J]. CURRENT DRUG METABOLISM, 2021, 22 (01) : 40 - 49
  • [8] Rhizoma Paridis saponins ameliorates hepatic fibrosis in rats by downregulating expression of angiogenesis-associated growth factors
    Han, Yanquan
    Pan, Lingyu
    Ran, Shan
    Song, Yan
    Sun, Fang-Fang
    Wang, Yong-Zhong
    Hong, Yan
    [J]. MOLECULAR MEDICINE REPORTS, 2019, 19 (05) : 3548 - 3554
  • [9] The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
    Harding, Simon D.
    Sharman, Joanna L.
    Faccenda, Elena
    Southan, Chris
    Pawson, Adam J.
    Ireland, Sam
    Gray, Alasdair J. G.
    Bruce, Liam
    Alexander, Stephen P. H.
    Anderton, Stephen
    Bryant, Clare
    Davenport, Anthony P.
    Doerig, Christian
    Fabbro, Doriano
    Levi-Schaffer, Francesca
    Spedding, Michael
    Davies, Jamie A.
    [J]. NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) : D1091 - D1106
  • [10] The Reliability of Estimating Ki Values for Direct, Reversible Inhibition of Cytochrome P450 Enzymes from Corresponding IC50 Values: A Retrospective Analysis of 343 Experiments
    Haupt, Lois J.
    Kazmi, Faraz
    Ogilvie, Brian W.
    Buckley, David B.
    Smith, Brian D.
    Leatherman, Sarah
    Paris, Brandy
    Parkinson, Oliver
    Parkinson, Andrew
    [J]. DRUG METABOLISM AND DISPOSITION, 2015, 43 (11) : 1744 - 1750